NCT02456012View on ClinicalTrials.gov

Long-term Oral Esomeprazole for Prevention of Peptic Ulcer Rebleeding in High-risk Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

268

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2020

Conditions
Peptic Ulcer Hemorrhage
Interventions
DRUG

oral esomeprazole 20 mg twice daily

for 36 weeks

DRUG

oral esomeprazole 20 mg once daily

for 36 weeks

Trial Locations (1)

70403

Helicobacter pylori study group, National Cheng Kung University Hospital, Tainan City

All Listed Sponsors
lead

Hsiu-Chi Cheng

OTHER

NCT02456012 - Long-term Oral Esomeprazole for Prevention of Peptic Ulcer Rebleeding in High-risk Patients | Biotech Hunter | Biotech Hunter